Back
MiNK Therapeutics, Inc. 10K Form
Sell
30
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.69
Seasonality Move:
-20.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INKT News And Ratings
See the #1 stock for the next 7 days that we like better than INKT
INKT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-941.3K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.94 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -3.03460 |
|---|---|
| Net Income (TTM): | $-12.4M |
| Gross Margin: | $-215.4K |
| Return on Equity: | 0% |
| Return on Assets: | -177.48% |
MiNK Therapeutics, Inc. Earnings Forecast
Key MiNK Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 3 years.
MiNK Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INKT |
| Website: | minktherapeutics.com |
Debt
| Debt-to-Equity Ratio: | -0.42 |
|---|---|
| Current Ratio: | 1.08 |
| Quick Ratio: | 1.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INKT Technical Analysis vs Fundamental Analysis
Sell
30
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy or a Sell?
-
MiNK Therapeutics, Inc. stock is rated a SellThe current MiNK Therapeutics, Inc. [INKT] share price is $11.50. The Score for INKT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.